paediatrics Brussels 17

The choice must be done on what it is expected at long term

TRISMUS

GROWTH and/or Brain RETARDATION 2-35% No known impact of IMRT

HEARING LOSS

Up to 50% IMRT : less than 10%

14 - 63 % (Gr. 1-2) 5% severe (Gr 3-4 ) < 30% Gr ½ with IMRT

CAVITIES Up to 65% < 25% with IMRT

XEROSTOMIA 50-95% Gr 1-2 (< 50 with IMRT ) 4 - 10% Gr 3 (<5% with IMRT )

NECK FIBROSIS 40-75% IMRT : 20-40% (gr1-2)

25-82% RELATIVE RISK > 14 NO IMPACT OF IMRT